The platform delivers advanced chemoproteomics solutions for protein design and development, enabling researchers to create proteins through predictive algorithms and AI-driven design suggestions.
It offers features like 3D structure prediction, which aids in optimizing thermostability, as well as codon expression, ensuring enhanced protein performance.
These tools significantly improve the efficiency and accuracy of protein engineering for various scientific applications.
Detail of startup:
- Location: Delft (Netherlands)
- Started in: 2021
- Founders: Stef Van Grieken, Jelle Prins
- Funding: $103M
- Funding rounds: 3
- Number of investors: 9
- Company website: cradle.bio
